Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis

doi:10.1084/jem.184.2.349

This Article

	Full Text (PDF, 759K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Zhang, G. X.
	Articles by Olsson, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Zhang, G. X.
	Articles by Olsson, T.


Social Bookmarking

	What's this?

ARTICLES

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis

GX Zhang, BG Xiao, M Bakhiet, P van der Meide, H Wigzell, H Link and T Olsson
Division of Neurology, Huddinge Hospital, Stockholm, Sweden.

CD4+ T cells have been shown to be crucial in the development of experimental autoimmune myasthenia gravis (EAMG). The role of CD8+ T cells in EAMG is less well established. We previously showed that antibody depletion of CD8+ T cells in rats effectively suppresses EAMG. To further study the role and relationship of CD4+ versus CD8+ T cells in induction of EAMG, CD4-/-, CD8-/-, and CD4-8- mutant C57BL/6 mice and the parent CD4+8- wild-type mice were immunized with Torpedo acetylcholine receptor (AChR) plus complete Freund's adjuvant. Clinical EAMG was nearly completely prevented in CD4-8-, CD4-/-, and CD8-/- mice. This was associated with strongly reduced AChR-specific T and B cell responses, and with reduced levels of AChR-reactive interferon gamma (IFN-gamma) and interleukin 4 (IL-4) mRNA-expressing cells in lymphoid organs when compared with CD4+8+ wild-type mice. We conclude that (a) both CD4+ and CD8+ T cells are essential for development of EAMG, and a collaboration between these cell types may be necessary; (b) CD4+ as well as CD8+ T cells secrete IFN-gamma and IL-4, and both cytokines are involved in the development of EAMG; and (c), besides T cells, other immune cells might also be responsible for help of anti- AChR antibody production.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Ben-David, H., Sharabi, A., Dayan, M., Sela, M., Mozes, E. (2007). The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc. Natl. Acad. Sci. USA 104: 17459-17464 [Abstract] [Full Text]
Ochoa-Reparaz, J., Riccardi, C., Rynda, A., Jun, S., Callis, G., Pascual, D. W. (2007). Regulatory T Cell Vaccination without Autoantigen Protects against Experimental Autoimmune Encephalomyelitis. J. Immunol. 178: 1791-1799 [Abstract] [Full Text]
Matsumoto, Y., Matsuo, H., Sakuma, H., Park, I.-K., Tsukada, Y., Kohyama, K., Kondo, T., Kotorii, S., Shibuya, N. (2006). CDR3 Spectratyping Analysis of the TCR Repertoire in Myasthenia Gravis.. J. Immunol. 176: 5100-5107 [Abstract] [Full Text]
Shao, H., Sun, S. L., Kaplan, H. J., Sun, D. (2004). Characterization of Rat CD8+ Uveitogenic T Cells Specific for Interphotoreceptor Retinal-Binding Protein 1177-1191. J. Immunol. 173: 2849-2854 [Abstract] [Full Text]
Hue, S., Monteiro, R. C., Berrih-Aknin, S., Caillat-Zucman, S. (2003). Potential Role of NKG2D/MHC Class I-Related Chain A Interaction in Intrathymic Maturation of Single-Positive CD8 T Cells. J. Immunol. 171: 1909-1917 [Abstract] [Full Text]
Paas-Rozner, M., Sela, M., Mozes, E. (2003). A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells. Proc. Natl. Acad. Sci. USA 100: 6676-6681 [Abstract] [Full Text]
Strobel, P., Helmreich, M., Menioudakis, G., Lewin, S. R., Rudiger, T., Bauer, A., Hoffacker, V., Gold, R., Nix, W., Schalke, B., Elert, O., Semik, M., Muller-Hermelink, H. K., Marx, A. (2002). Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas. Blood 100: 159-166 [Abstract] [Full Text]
Taneja, V., Taneja, N., Paisansinsup, T., Behrens, M., Griffiths, M., Luthra, H., David, C. S. (2002). CD4 and CD8 T Cells in Susceptibility/Protection to Collagen-Induced Arthritis in HLA-DQ8-Transgenic Mice: Implications for Rheumatoid Arthritis. J. Immunol. 168: 5867-5875 [Abstract] [Full Text]
Im, S.-H., Barchan, D., Maiti, P. K., Fuchs, S., Souroujon, M. C. (2001). Blockade of CD40 Ligand Suppresses Chronic Experimental Myasthenia Gravis by Down-Regulation of Th1 Differentiation and Up-Regulation of CTLA-4. J. Immunol. 166: 6893-6898 [Abstract] [Full Text]
Ostlie, N. S., Karachunski, P. I., Wang, W., Monfardini, C., Kronenberg, M., Conti-Fine, B. M. (2001). Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis. J. Immunol. 166: 4853-4862 [Abstract] [Full Text]
Deng, C., Goluszko, E., Christadoss, P. (2001). Fas/Fas Ligand Pathway, Apoptosis, and Clonal Anergy Involved in Systemic Acetylcholine Receptor T Cell Epitope Tolerance. J. Immunol. 166: 3458-3467 [Abstract] [Full Text]
Faber-Elmann, A., Grabovsky, V., Dayan, M., Sela, M., Alon, R., Mozes, E. (2000). Cytokine profile and T cell adhesiveness to endothelial selectins: in vivo induction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand. Int Immunol 12: 1651-1658 [Abstract] [Full Text]
Hoffacker, V., Schultz, A., Tiesinga, J. J., Gold, R., Schalke, B., Nix, W., Kiefer, R., Muller-Hermelink, H. K., Marx, A. (2000). Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96: 3872-3879 [Abstract] [Full Text]
Shi, F.-D., Li, H., Wang, H., Bai, X., van der Meide, P. H., Link, H., Ljunggren, H.-G. (1999). Mechanisms of Nasal Tolerance Induction in Experimental Autoimmune Myasthenia Gravis: Identification of Regulatory Cells. J. Immunol. 162: 5757-5763 [Abstract] [Full Text]
Zhang, G.-X., Xiao, B.-G., Bai, X.-F., van der Meide, P. H., Orn, A., Link, H. (1999). Mice with IFN-{gamma} Receptor Deficiency Are Less Susceptible to Experimental Autoimmune Myasthenia Gravis. J. Immunol. 162: 3775-3781 [Abstract] [Full Text]
Hohlfeld, R. (1999). Myasthenia gravis. Neurology 52: 443-443 [Full Text]
Wang, Z.-Y., Karachunski, P. I., Howard, J. F. Jr., Conti-Fine, B. M. (1999). Myasthenia in SCID mice grafted with myasthenic patient lymphocytes: Role of CD4 and CD8 cells. Neurology 52: 484-484 [Abstract] [Full Text]
Balasa, B., Deng, C., Lee, J., Christadoss, P., Sarvetnick, N. (1998). The Th2 Cytokine IL-4 Is Not Required for the Progression of Antibody-Dependent Autoimmune Myasthenia Gravis. J. Immunol. 161: 2856-2862 [Abstract] [Full Text]
Raju, R., Zhan, W.-Z., Karachunski, P., Conti-Fine, B., Sieck, G. C., David, C. (1998). Polymorphism at the HLA-DQ Locus Determines Susceptibility to Experimental Autoimmune Myasthenia Gravis. J. Immunol. 160: 4169-4174 [Abstract] [Full Text]